Albemarle Corporation
NYSE:ALBChemicals - Specialty
-$6.21 today
- Market cap
- $10.13B
- Beta
- 1.31
- P/E (TTM)
- -81.1
- EPS (TTM)
- -$1.98
- Dividend yield
- 1.01%
Volume 2.16M
Average 2.29M
ALB Other Current Liabilities
Short-term obligations not reported separately, such as accrued expenses.
Albemarle CorporationNYSE: ALB
Other Current Liabilities · Q2 FY2026 · quarter ended Jun 2026
Other current liabilities remains negative
Q2 FY2026 other current liabilities was $441.24M, compared with $0 a year earlier. Over 3 fiscal years it compounded at +31.5% a year.
Context
- Other current liabilities amounted to 2.8% of total assets at the end of Q2 FY2026, up 2.8 pp from a year earlier.
- Other current liabilities increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
Sources:Balance SheetText generated from reported figures; not investment advice.
Other Current Liabilities history
USD · from the balance sheet
- Latest · FY2025
- 331.96M USD
- Year-over-year change
- +111.2%
- 4-year CAGR
- +34.7%
| Period | Period end | Other Current Liabilities | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 331.96M | +111.2% |
| FY2024 | 2024-12-31 | 157.15M | -6.7% |
| FY2023 | 2023-12-31 | 168.36M | +15.4% |
| FY2022 | 2022-12-31 | 145.89M | +44.8% |
| FY2021 | 2021-12-31 | 100.72M | — |
Other Current Liabilities vs competitors
How ALB compares with its peers on the latest reported figures
- ALB's Jun 2026 other current liabilities of $441.24M is the 2nd highest of the 4 companies compared; the peer median is $157.78M.
- Other current liabilities amounts to 2.8% of total assets for ALB, versus a peer median of 5.1%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | $1.17B | +211.2% | -30.3% | 7.0% | |
| Jun 2026 | $441.24M | — | +31.5% | 2.8% | |
| Mar 2026 | $157.78M | +3214.0% | +365.1% | 5.1% | |
| Mar 2026 | $7.13M | +31.1% | — | 1.8% | |
| Peer median (excluding ALB) | $157.78M | +211.2% | +167.4% | 5.1% | |
Competitors are the stored peer set for ALB. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 439.27M | 1.5B | 889.9M | 1.19B | 1.62B |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 700.06M | 1.45B | 1.84B | 1.07B | 764.77M |
| Inventory | 798.62M | 2.08B | 2.16B | 1.5B | 1.18B |
| Other Current Assets | 5.8M | 6.72M | 6.6M | 4.75M | 374.19M |
| Total Current Assets | 1.99B | 5.19B | 5.22B | 3.84B | 4.01B |
| Property, Plant & Equipment (Net) | 6.06B | 7.09B | 9.63B | 9.45B | 8.73B |
| Goodwill | 1.6B | 1.62B | 1.63B | 1.58B | 1.5B |
| Intangible Assets | 308.95M | 287.87M | 261.86M | 230.75M | 214.23M |
| Long-term Investments | 912.01M | 1.15B | 1.37B | 1.12B | 900.93M |
| Tax Assets | 18.8M | 46.43M | 22.43M | 53.61M | 17.54M |
| Other Non-current Assets | 78.7M | 75.95M | 137.25M | 332.26M | 1B |
| Total Non-current Assets | 8.98B | 10.27B | 13.05B | 12.77B | 12.37B |
| Total Assets | 10.97B | 15.46B | 18.27B | 16.61B | 16.37B |
| Account Payables | 647.99M | 2.05B | 2.09B | 943.89M | 913.53M |
| Short-term Debt | 389.92M | 2.13M | 625.76M | 398.02M | 74.08M |
| Tax Payables | 27.67M | 134.88M | 255.16M | 95.28M | 0 |
| Deferred Revenue | 0 | 0 | 0 | 2.12M | 93.09M |
| Other Current Liabilities | 100.72M | 145.89M | 168.36M | 157.15M | 331.96M |
| Total Current Liabilities | 1.87B | 2.74B | 3.56B | 1.97B | 1.8B |
| Long-term Debt | 2B | 3.21B | 3.54B | 3.12B | 3.12B |
| Deferred Tax Liabilities | 353.28M | 480.77M | 558.43M | 358.03M | 368.28M |
| Deferred Revenue (Non-current) | 0 | 0 | 78.03M | 78.03M | 340.53M |
| Other Non-current Liabilities | 809.58M | 729.65M | 753.95M | 789.79M | 863.33M |
| Total Non-current Liabilities | 3.29B | 4.52B | 5.05B | 4.44B | 4.79B |
| Total Liabilities | 5.17B | 7.27B | 8.61B | 6.41B | 6.59B |
| Common Stock | 1.17M | 1.17M | 1.17M | 1.18M | 1.18M |
| Retained Earnings | 3.1B | 5.6B | 6.99B | 5.48B | 4.61B |
| Accumulated OCI | (392.45M) | (560.66M) | (528.53M) | (742.06M) | (334.81M) |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 180.34M | 208.22M | 252.92M | 238.17M | 248.1M |
| Total Equity | 5.81B | 8.19B | 9.67B | 10.2B | 9.78B |
| Total Debt | 2.52B | 3.32B | 4.28B | 3.62B | 3.3B |
| Net Debt | 2.08B | 1.82B | 3.39B | 2.42B | 1.68B |
Albemarle Corporation
NYSE:ALB
Intrinsic Alpha fair value
Locked
Current Price
$85.82
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.